BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7502792)

  • 1. Specific immunological non-responsiveness induced by antigens via mucosal surfaces.
    Metzler B; Wraith DC
    Adv Exp Med Biol; 1995; 371B():1243-4. PubMed ID: 7502792
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis.
    Mokhtarian F; Shirazian T; Batuman O; Shi Y
    Ann N Y Acad Sci; 1996 Feb; 778():414-7. PubMed ID: 8611007
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune deviation during the induction of tolerance by way of nasal installation: nasal installation itself can induce Th-2 responses and exacerbation of disease.
    Melo ME; Goldschmidt TJ; Bhardwaj V; Ho L; Miller A; Sercarz E
    Ann N Y Acad Sci; 1996 Feb; 778():408-11. PubMed ID: 8611005
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral tolerance in autoimmune encephalomyelitis. In vivo reversal of anergy.
    Gienapp I; Cox K; Javed N; Whitacre C
    Ann N Y Acad Sci; 1996 Feb; 778():382-3. PubMed ID: 8610997
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of autoimmune diseases by oral tolerance to autoantigens.
    Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M
    Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a direct role for mucosal immune cells in the induction of oral tolerance.
    Furrie E; Turner M; Strobel S
    Adv Exp Med Biol; 1995; 371B():1235-8. PubMed ID: 7502790
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
    Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental autoimmune encephalomyelitis in SJL mice by oral administration of retro-inverso derivative of encephalitogenic epitope P87-99.
    Marino M; Ippolito A; Fassina G
    Eur J Immunol; 1999 Aug; 29(8):2560-6. PubMed ID: 10458771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral beta interferon on subsequent immune responsiveness.
    Nelson PA; Akselband Y; Dearborn SM; Al-Sabbagh A; Tian ZJ; Gonnella PA; Zamvil SS; Chen Y; Weiner HL
    Ann N Y Acad Sci; 1996 Feb; 778():145-55. PubMed ID: 8610968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of gut flora has no effect on the induction of oral tolerance to ovalbumin.
    Furrie E; Turner M; Strobel S
    Adv Exp Med Biol; 1995; 371B():1239-41. PubMed ID: 7502791
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model.
    Issazadeh S; Zhang M; Sayegh MH; Khoury SJ
    J Immunol; 1999 Jan; 162(2):761-5. PubMed ID: 9916696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tolerance in myelin basic protein TCR transgenic mice.
    Meyer A; Gienapp I; Cox K; Goverman J; Hood L; Whitacre C
    Ann N Y Acad Sci; 1996 Feb; 778():412-3. PubMed ID: 8611006
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis.
    Metzler B; Wraith DC
    Ann N Y Acad Sci; 1996 Feb; 778():228-42. PubMed ID: 8610976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal suppression by oral pre-treatment with ovalbumin and its conversion into stimulation when ovalbumin was conjugated to cholera toxin or its B subunit.
    van der Heijden PJ; Stok W; Bianchi AT
    Adv Exp Med Biol; 1995; 371B():1251-5. PubMed ID: 7502794
    [No Abstract]   [Full Text] [Related]  

  • 16. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
    J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.
    Miron N; Feldrihan V; Berindan-Neagoe I; Cristea V
    Immunol Invest; 2014; 43(3):267-77. PubMed ID: 24354887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
    Kennedy KJ; Smith WS; Miller SD; Karpus WJ
    J Immunol; 1997 Jul; 159(2):1036-44. PubMed ID: 9218627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses.
    Vogel K; Kantor J; Wood L; Rivera R; Schlom J
    Cell Immunol; 1998 Nov; 190(1):61-7. PubMed ID: 9826447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance to ovalbumin in mice: effect of some parameters on the induction and persistence of the suppression of systemic IgE and IgG antibody responses.
    Moreau MC; Coste M; Gaboriau V; Dubuquoy C
    Adv Exp Med Biol; 1995; 371B():1229-34. PubMed ID: 7502789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.